VENOM RESEARCH SOLUTIONS

About Us

Based at Discovery Park in Kent, UK, a global leader for science and enterprise, with world class laboratories

Venomtech - Venom Research Solutions

 

Venomtech was founded in 2010 by Steve Trim to help solve one of the problems often encountered as a pharmaceutical scientist - finding adequate new drug leads.

We are a biotechnology company with a focus on developing novel venom-derived screening tools, and lead compounds. Our passion and drive for drug discovery is intrinsically linked to our desire to advance human healthcare and to our personal experience of the challenges in drug discovery. We use venoms from a range of vertebrate and invertebrate species including snakes, spiders and centipedes.

Our products and services address one of the most common frustrations in drug discovery: the failure to find promising drug candidates in available libraries of synthetic chemical molecules.

 

We have:

  • A wide array of venoms, in sufficient quantities for repeated experiments, to obtain consistent results.
  • Many proprietary skills and unique technical facilities to extract venoms.
  • Developed a systematic approach that involves separating venoms into smaller, simpler fractions, providing researchers with targeted high-quality venom preparations in a ready to use format.

Collections of new and promising compounds, such as venoms, increase the likelihood of finding effective, unique and high-value drug candidates for difficult targets.

Venomtech specialises in this field, and has made sales to customers across the world, illustrated on the map below:

 

Management Team

Steve Trim BSc, CBiol, MRSB
Founder/ CSO/ General Manager

Steve TrimSteve spent a decade working as a molecular biologist in drug discovery at Pfizer, working extensively on pain therapeutics and developing expertise in the tissue repair, gastrointestinal and respiratory fields. Having worked across molecular biology, pharmacology, biochemistry and anatomy, Steve has a deep understanding of drug discovery and the use of venoms and toxins in this area. Drawing on this experience, he founded Venomtech with the goal of solving the problems the industry faces in finding new medicines.

Steve Trim - LinkedIn

 

Professor Karol Sikora, MA, MBBChir, PhD, MD, FRCR, FRCP, FRCPE, FFPM
Interim Chairman

Professor Karol SikoraKarol is a consultant 0ncologist at Hammersmith Hospital, London, medical director of Proton Partners International and dean of the University of Buckingham's medical school. He launched CancerPartnersUK, Britain's largest independent network of innovative cancer treatment centres. He was Chief of the World Health Organisation's Cancer Programme between 1997 and 1999 and has been an adviser to the UN's International Atomic Energy Agency. Karol provides invaluable expertise in oncology and therapeutics.

Karol Sikora - LinkedIn

 

Doctor Paul Grant​ MSc. PhD
Commercial Director

Dr Paul GrantPaul has 10 years of experience in academic research, including time spent at Kings College London and St. Georges Hospital, London,  as well as 12 years experience in drug discovery business development. In this time, he has developed deep industry knowledge, contacts and scientific credibility. Paul has worked with major pharmaceutical, biotechnology, academic, CRO and diagnostic companies across Europe, USA and Asia.

Paul Grant - LinkedIn

 

Available Products

Anti-inflammatory cosmetic skin Anti-inflammatory 
Cosmetic peptides to soothe skin and reduce inflammation
Antipollution 
Cosmetic peptides to protect skin from toxins and pollutants
VenomSELECTTM 
Our bespoke cosmetic peptide design service

 

Target-based 
Target-based venom arrays for hard-to-hit drug targets
Therapeutic areas 
Venom arrays for antimicrobial, pain, cancer research, etc.
Custom Arrays 
Venom arrays designed by us for your target or research area

 

Additional Resources

Science Exchange
Request a quote via the world's leading and most secure R&D outsourcing platform

Papers and Posters venom

Papers & Posters
Helpful publications from our team, our partners and key industry sources

People and partners venom

FAQs
Find the answers to your most frequently asked questions